Roth Capital upgraded shares of HIVE Blockchain Technologies (CVE:HIV – Free Report) to a strong-buy rating in a research note published on Wednesday,Zacks.com reports.
HIV has been the subject of several other reports. Northland Capmk raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Thursday, September 19th. Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Tuesday, October 29th.
Read Our Latest Stock Analysis on HIVE Blockchain Technologies
HIVE Blockchain Technologies Price Performance
Featured Stories
- Five stocks we like better than HIVE Blockchain Technologies
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- CD Calculator: Certificate of Deposit Calculator
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Industrial Products Stocks Investing
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
